Choledocholithiasis in pregnancy: When and how to perform ERCP?

Prevalence of cholelithiasis in pregnancy varies from 1 % to 12 % depending on the study population. Approximately 1 % of those with gallstone disease develop symptoms. The diagnosis is made by clinical signs, laboratory tests and transabdominal ultrasound (TUS) for evaluation of the gallbladder and bile ducts. Magnetic resonance cholangiopancreatography (MRCP) should be considered for indeterminate cases. It allows to identify patients with clear ducts e. g. after spontaneous stone passage who do not need therapeutic interventions. On the other hand, in case of stones, it enables the number, size and location to be determined. This provides important information for therapy. Endoscopic ultrasound (EUS) can be considered as alternative for diagnosis. Its invasiveness is relative if the procedure is performed in the same session as ERCP that should be limited to proving existence of ductal stones [1].

Publikationsverlauf

Artikel online veröffentlicht:
07. Oktober 2020

• References

• 1 Shah JN, Bhat YM, Hamerski CM. et al. Feasibility of nonradiation EUS-based ERCP in patients with uncomplicated choledocholithiasis (with video). Gastrointest Endosc 2016; 84: 76-79
• 2 Othman MO, Stone E, Hashimi M. et al. Conservative management of cholelithiasis and its complications in pregnancy is associated with recurrent symptoms and more emergency department visits. Gastrointest Endosc 2012; 76: 564-569
• 3 Azab M, Bharadwaj S, Jayaraj M. et al. Safety of endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy: A systematic review and meta-analysis. Saudi J Gastroenterol 2019; 25: 341-354
• 4 Dumonceau JM, Garcia-Fernandez FJ, Verdun FR. et al. Radiation protection in digestive endoscopy: European Society of Digestive Endoscopy (ESGE) Guideline. Endoscopy 2012; 44: 408-424
• 5 Liao C, Thosani N, Kothari S. et al. Radiation exposure to patients during ERCP is significantly higher with low-volume endoscopists. Gastrointest Endosc 2015; 81: 391-398
• 6 Shergill AK, Ben-Menachem T, Chandrasekhara V. et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2012; 76: 18-24
• 7 Tang S, Mayo MJ, Rodriguez-Frias E. et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009; 69: 453-461
• 8 Kahaleh M, Hartwell GD, Arseneau KO. et al. Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc 2004; 60: 287-292
• 9 Smith I, Gaidhane M, Goode A. et al. Safety of endoscopic retrograde cholangiopancreatography in pregnancy: Fluoroscopy time and fetal exposure, does it matter?. World J Gastrointest Endosc 2013; 5: 148-153
• 10 Shelton J, Linder JD, Rivera-Alsina ME. et al. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc 2008; 67: 364-368
• 11 Huang P, Zhang H, Zhang XF. et al. Comparison of endoscopic retrograde cholangiopancreatography performed without radiography and with ultrasound-guidance in the management of acute pancreaticobiliary disease in pregnant patients. Chin Med J (Engl) 2013; 126: 46-50
• 12 Li S, Dargavel C, Muradali C. et al. Real-time transabdominal ultrasound-guided ERCP is feasible and effective in pregnancy: a case series. EIO 2020; 1: 1807-CR.R1
• 13 Inamdar S, Berzin TM, Sejpal DV. et al. Pregnancy is a risk factor for pancreatitis after endoscopic retrograde cholangiopancreatography in a national cohort study. Clin Gastroenterol Hepatol 2016; 14: 107-114
• 14 Barakat MT, Girotra M, Choudhary A. et al. A prospective evaluation of radiation-free direct solitary cholangioscopy for the management of choledocholithiasis. Gastrointest Endosc 2018; 87: 584-589